Anthony F Shields

64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer

Karen Campbell, Ian Krop, Barry A Siegel, 2017, Clinical Cancer Research.

A Phase II Study of 3′-Deoxy-3′-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688

Fenghai Duan, Mark Muzi, Linda Hovanessian-Larsen, 2015, The Journal of Nuclear Medicine.

Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.

Barry A Siegel, Barry A. Siegel, R. Coleman, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PET imaging of cellular proliferation.

David A Mankoff, Kenneth A Krohn, D. Mankoff, 2005, Radiologic clinics of North America.

PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls.

A. Shields, Anthony F Shields, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.

Jay Burmeister, Todd Bossenberger, Edgar Ben-Josef, 2004, International journal of radiation oncology, biology, physics.

Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

John L Marshall, P. Philip, R. Goldberg, 2018, Molecular Cancer Research.

Glucocorticoid Receptor Status Is a Principal Determinant of Variability in the Sensitivity of Non–Small-Cell Lung Cancer Cells to Pemetrexed

G. Bepler, A. Shields, S. Gadgeel, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.